Paid Clinical Trials Santa Fe

Discover 373 paid clinical trials in Santa Fe, New Mexico. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 373

Is the Degree of Perceived Effort During Resistance Exercise Important for Improvements in Blood GlucoseIs the Degree of Perceived Effort During Resistance Exercise Important for Improvements in Blood Glucose

Recruiting

Sponsor:

University of New Mexico

Location:

Albuquerque NM

Code:

NCT06208189

Conditions

PreDiabetes

Type 2 Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

High-effort session

Low-effort session

Control

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLCTo Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Recruiting

PHASE3

Sponsor:

Shanghai Henlius Biotech

Location:

Santa Fe NM, Colorado Springs CO, Lubbock TX, Golden COshow 85 more

Code:

NCT05468489

Conditions

Extensive Stage Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Serplulimab + chemotherapy (carboplatin-etoposide)

Atezolizumab + chemotherapy (carboplatin-etoposide)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Rio Rancho NM, Albuquerque NM, Durango CO, Pueblo COshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Mindfulness for Alcohol Abusing OffendersMindfulness for Alcohol Abusing Offenders

Recruiting

Sponsor:

The Mind Research Network

Location:

Albuquerque NM

Code:

NCT03883646

Conditions

Alcohol Abuse

Criminal Behavior

Eligibility Criteria

Sex: Female

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Mindfulness

Relapse Prevention

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening IschemiaPROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

Recruiting

Sponsor:

LimFlow, Inc.

Location:

Albuquerque NM, Dallas TX, La Jolla CA, Torrance CAshow 21 more

Code:

NCT05313165

Conditions

Critical Limb Ischemia

Chronic Limb-Threatening Ischemia

Peripheral Arterial Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

LimFlow Stent Graft System

A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental VitiligoA 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo

Recruiting

PHASE3

Sponsor:

Pfizer

Location:

Albuquerque NM, Dallas TX, San Antonio TX, Encinitas CAshow 23 more

Code:

NCT06163326

Conditions

Vitiligo

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Ritlecitinib

Ritlecitinib 100 mg

Placebo

A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial HyperplasiaA Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

Recruiting

PHASE2

Sponsor:

Washington University School of Medicine

Location:

Albuquerque NM, Oklahoma City OK, Saint Louis MO

Code:

NCT05903131

Conditions

Endometrial Hyperplasia

Grade 1 Endometrial Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Telemedicine behavioral weight intervention

Progestin

Enhanced usual care

Levonorgestrel-releasing IUD.

Enlighten Study: The EV-ICD Post Approval RegistryEnlighten Study: The EV-ICD Post Approval Registry

Recruiting

Sponsor:

Medtronic

Location:

Albuquerque NM, Fort Worth TX, Plano TX, Dallas TXshow 47 more

Code:

NCT06048731

Conditions

Ventricular Arrhythmia

Tachycardia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Defibrillation using EV-ICD

FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Recruiting

PHASE2

PHASE3

Sponsor:

Fusion Pharmaceuticals Inc.

Location:

Albuquerque NM, Dallas TX, Omaha NE, Irvine CAshow 11 more

Code:

NCT06402331

Conditions

Metastatic Castration-resistant Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FPI-2265

A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid MalignanciesA Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies

Recruiting

PHASE1

PHASE2

Sponsor:

AstraZeneca

Location:

Albuquerque NM, Irvine CA, Duarte CA, Santa Monica CAshow 16 more

Code:

NCT05123482

Conditions

Breast Cancer

Biliary Tract Carcinoma

Ovarian Cancer

Endometrial Cancer

Squamous Non-Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AZD8205

AZD8205 and AZD2936 (Rilvegostomig)

AZD8205 and AZD5305 (saruparib)

AZD8205 and AZD5305 (saruparib) and AZD2936 (rilvegostomig)